{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:40:25Z","timestamp":1760661625500,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Australian and New Zealand Journal of Public Health"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.anzjph.2025.100272","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:41:31Z","timestamp":1757594491000},"page":"100272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Active follow-up of hepatitis C notifications by public health staff improves treatment uptake"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4802-6977","authenticated-orcid":false,"given":"Siddhanth","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0555-382X","authenticated-orcid":false,"given":"Erica","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kane","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3088-4516","authenticated-orcid":false,"given":"Benjamin","family":"Scalley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"isbn-type":"print","year":"2024","series-title":"Australia\u2019s progress towards hepatitis C elimination: annual report 2024","key":"10.1016\/j.anzjph.2025.100272_bib1","ISBN":"https:\/\/id.crossref.org\/isbn\/9780646704562"},{"year":"2024","series-title":"HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2024","author":"King","key":"10.1016\/j.anzjph.2025.100272_bib2"},{"year":"2022","series-title":"HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2022","author":"King","key":"10.1016\/j.anzjph.2025.100272_bib3"},{"issue":"11","key":"10.1016\/j.anzjph.2025.100272_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2468-1253(18)30304-2","article-title":"Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis","volume":"3","author":"Hajarizadeh","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.anzjph.2025.100272_bib5","article-title":"Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study","volume":"18","author":"Scott","year":"2022","journal-title":"Lancet Reg Health\u2013Western Pacific"},{"issue":"6","key":"10.1016\/j.anzjph.2025.100272_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jvh.12852","article-title":"Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia","volume":"25","author":"Hajarizadeh","year":"2018","journal-title":"J Viral Hepat"},{"issue":"11","key":"10.1016\/j.anzjph.2025.100272_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207226","article-title":"Beyond interferon side effects: what residual barriers exist to DAA hepatitis C treatment for people who inject drugs?","volume":"13","author":"Madden","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.anzjph.2025.100272_bib8","doi-asserted-by":"crossref","DOI":"10.17061\/phrp30342010","article-title":"Public health unit notifications of hepatitis C and their follow-up in South western Sydney, Australia","volume":"31","author":"O'Brien","year":"2021","journal-title":"Public Health Res Pract"},{"issue":"1","key":"10.1016\/j.anzjph.2025.100272_bib9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1186\/s12889-023-16017-8","article-title":"Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs\u2013a scoping review of the qualitative evidence","volume":"23","author":"Balsom","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.anzjph.2025.100272_bib10","doi-asserted-by":"crossref","DOI":"10.33321\/cdi.2023.47.62","article-title":"Using notifications data to increase hepatitis C testing and treatment rates in Queensland","volume":"47","author":"Carpenter","year":"2023","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.anzjph.2025.100272_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104184","article-title":"Connecting patients notified with hepatitis C to treatment (CONNECT Study): a randomized controlled trial of active case management by a health department to support primary care practitioners","volume":"121","author":"Marukutira","year":"2023","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.anzjph.2025.100272_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103280","article-title":"\u201cIt's time!\u201d: a qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C","volume":"97","author":"Walker","year":"2021","journal-title":"Int J Drug Pol"},{"issue":"29","key":"10.1016\/j.anzjph.2025.100272_bib13","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.29.2400028","article-title":"A pilot project harnessing surveillance systems to support clinicians providing clinical care for people diagnosed with hepatitis C in Victoria, Australia, September 2021 to 31 March 2022","volume":"29","author":"Abbott","year":"2024","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.anzjph.2025.100272_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jamasurg.2021.0531","article-title":"SQUIRE reporting guidelines for quality improvement studies","volume":"156","author":"Kelz","year":"2021","journal-title":"JAMA Surg"},{"year":"2025","series-title":"Acknowledgement of country and people","key":"10.1016\/j.anzjph.2025.100272_bib15"},{"year":"2024","series-title":"Epidemiology of notifiable infectious diseases in metropolitan Perth: annual report 2023","key":"10.1016\/j.anzjph.2025.100272_bib16"},{"year":"2021","series-title":"Greater Perth - 2021 Census Aboriginal and\/or Torres Strait Islander people QuickStats Canberra","key":"10.1016\/j.anzjph.2025.100272_bib17"},{"key":"10.1016\/j.anzjph.2025.100272_bib18","unstructured":"Government of Western Australia, Public Health Act, 2016. Part 9, pages 64-65."},{"year":"2025","series-title":"Disability and ageing","key":"10.1016\/j.anzjph.2025.100272_bib19"},{"year":"2024","series-title":"Department of health and aged care. Medicare benefits schedule - item 69499","key":"10.1016\/j.anzjph.2025.100272_bib20"},{"key":"10.1016\/j.anzjph.2025.100272_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102633","article-title":"A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment","volume":"76","author":"Palmer","year":"2020","journal-title":"Int J Drug Pol"},{"year":"2022","series-title":"WA health System\u2014HSUWA\u2014Pacts industrial agreement","key":"10.1016\/j.anzjph.2025.100272_bib22"},{"issue":"4","key":"10.1016\/j.anzjph.2025.100272_bib23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/jgh.13223","article-title":"Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia","volume":"31","author":"Scott","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"year":"2023","series-title":"6th national hepatitis C strategy 2023-2030 [for consultation]","key":"10.1016\/j.anzjph.2025.100272_bib24"},{"year":"2022","series-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030","key":"10.1016\/j.anzjph.2025.100272_bib25"},{"year":"2024","series-title":"Regional population: 2022-23 financial year Canberra","key":"10.1016\/j.anzjph.2025.100272_bib26"},{"issue":"3","key":"10.1016\/j.anzjph.2025.100272_bib27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/S026646232000029X","article-title":"Analysis of PBAC submissions and outcomes for medicines (2010\u20132018)","volume":"36","author":"Lybrand","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"year":"2023","series-title":"Tracking the progress 2022: national hepatitis C strategy","key":"10.1016\/j.anzjph.2025.100272_bib28"},{"issue":"1","key":"10.1016\/j.anzjph.2025.100272_bib29","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1186\/s12889-023-17066-9","article-title":"Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: a mixed-methods evaluation of the tasmanian eliminate hepatitis C Australia outreach project, 2020\u20132022","volume":"23","author":"Dawe","year":"2023","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.anzjph.2025.100272_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38792","article-title":"Community-based point-of-diagnosis hepatitis C treatment for marginalized populations: a nonrandomized controlled trial","volume":"6","author":"Morris","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Australian and New Zealand Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1326020025000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1326020025000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T22:31:25Z","timestamp":1760653885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1326020025000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1326020025000536"],"URL":"https:\/\/doi.org\/10.1016\/j.anzjph.2025.100272","relation":{},"ISSN":["1326-0200"],"issn-type":[{"type":"print","value":"1326-0200"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active follow-up of hepatitis C notifications by public health staff improves treatment uptake","name":"articletitle","label":"Article Title"},{"value":"Australian and New Zealand Journal of Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anzjph.2025.100272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier B.V. on behalf of Public Health Association of Australia.","name":"copyright","label":"Copyright"}],"article-number":"100272"}}